These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 5034578)
1. [Use of protective agents during the treatment of lung neoplasms with cyclophosphane]. Trakhtenberg AKh; Bergut FA; Trubnikova EN; Shurina NA; Batinov IN Sov Med; 1972 Jan; 35(1):40-4. PubMed ID: 5034578 [No Abstract] [Full Text] [Related]
2. [Treatment of lung neoplasms with massive single doses of cyclophosphane in combination with the protector cystaphos]. Batinov IN; Trakhtenberg AK; Trubnikova EN; Sukhin GM Vopr Onkol; 1971 Dec; 17(12):83-4. PubMed ID: 5144166 [No Abstract] [Full Text] [Related]
3. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer]. Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593 [TBL] [Abstract][Full Text] [Related]
4. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide]. Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy in squamous cell carcinoma of the lung. Krzakowski MJ; Swierz J Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285 [TBL] [Abstract][Full Text] [Related]
6. [Radioisotope study of liver function during treatment of lung cancer with cyclophosphane]. Starinskiĭ VV; Trakhtenberg AKh; Batinov IN Med Radiol (Mosk); 1970 Apr; 15(4):32-8. PubMed ID: 5452195 [No Abstract] [Full Text] [Related]
7. [Morphology of pulmonary carcinoma following pre-operative cyclophosphane therapy]. Kobozeva SA; Trakhtenberg AKh; Batinov IN Grudn Khir; 1971; 13(6):61-6. PubMed ID: 5145943 [No Abstract] [Full Text] [Related]
8. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung. Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471 [No Abstract] [Full Text] [Related]
9. [Effect of zymosan on the peripheral blood picture (clinical cases)]. Zitare II; Kundzinia IA; Bramberga VM Klin Lech Zlokach Novoobraz; 1968; 11():113-6. PubMed ID: 4972950 [No Abstract] [Full Text] [Related]
10. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer. Lindgren D; Cadman E; Erichson R; Grann V; Sachs K Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015 [TBL] [Abstract][Full Text] [Related]
11. [Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)]. Decroix G; Sors C; Feldman A; Fournier M Bull Mem Soc Med Hop Paris; 1968; 119(2):169-78. PubMed ID: 5670365 [No Abstract] [Full Text] [Related]
12. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung]. Sanz Ortiz J; Saiz García F Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560 [No Abstract] [Full Text] [Related]
13. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers. Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477 [TBL] [Abstract][Full Text] [Related]
14. [Shifts in the serum protein picture in patients with malignant neoplasms during chemotherapy of a complex nature with zymosan]. Zakenfel'd GK Klin Lech Zlokach Novoobraz; 1968; 11():207-14. PubMed ID: 5725407 [No Abstract] [Full Text] [Related]
15. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results]. Pipino G; Germiniani R; Maione G; Fazio FM Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792 [No Abstract] [Full Text] [Related]
16. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer. Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587 [TBL] [Abstract][Full Text] [Related]
17. [Urothelial carcinoma of the bladder following cyclophosphamide therapy]. Blume B; Rabe F; Theuring F Z Urol Nephrol; 1984 Jan; 77(1):7-9. PubMed ID: 6702330 [TBL] [Abstract][Full Text] [Related]
18. [Immunoelectrophoretic evaluation of lung neoplasms and pulmonary tuberculosis]. Shimada K; Tsuji S Rinsho Byori; 1974 Oct; 22(10 Suppl):257. PubMed ID: 4475849 [No Abstract] [Full Text] [Related]
19. [Results of radiologic and cytostatic combination therapy in malignant diseases]. Hammer B Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442 [No Abstract] [Full Text] [Related]
20. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum). Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]